Protease inhibitors as models for the study of oxidative folding

Antioxidants and Redox Signaling

Volumn 14, Issue 1, 2011, Pages 97-112

  Arolas, Joan L ^a,b   Ventura, Salvador ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b CSIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYPEPTIDASE; HIRUDIN; PROTEINASE INHIBITOR; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; TRYPSIN INHIBITOR;

ASCARIS; DISULFIDE BOND; ISOMER; LEECH; LEUKOCYTE; MOLECULAR MECHANICS; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN FOLDING; REVIEW; TICK;

ANIMALS; APROTININ; HIRUDINS; HUMANS; MODELS, MOLECULAR; OXIDATION-REDUCTION; PROTEIN FOLDING;

ASCARIS; BOVINAE; HIRUDINIDA; IXODIDA;

EID: 78649488803     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2010.3456     Document Type: Review

References (81)

1. Antuch W, Guntert P, Billeter M, Hawthorne T, Grossen-bacher H, and Wuthrich K. NMR solution structure of the recombinant tick anticoagulant protein (rTAP), a factor Xa inhibitor from the tick Ornithodoros moubata. FEBS Lett 352: 251-257, 1994.
2. Arolas JL, Aviles FX, Chang JY, and Ventura S. Folding of small disulfide-rich proteins: clarifying the puzzle. Trends Biochem Sci 31: 292-301, 2006.
3. Arolas JL, Bronsoms S, Aviles FX, Ventura S, and Som-merhoff CP. Oxidative folding of leech-derived tryptase inhibitor via native disulfide-bonded intermediates. Antioxid Redox Signal 10: 77-85, 2008.
4. Arolas JL, Bronsoms S, Lorenzo J, Aviles FX, Chang JY, and Ventura S. Role of kinetic intermediates in the folding of leech carboxypeptidase inhibitor.J Biol Chem 279: 37261-37270, 2004.
5. Arolas JL, Bronsoms S, Ventura S, Aviles FX, and Calvete JJ. Characterizing the tick carboxypeptidase inhibitor: molecular basis for its two-domain nature. J Biol Chem 281: 22906-22916, 2006.
6. Arolas JL, Castillo V, Bronsoms S, Aviles FX, and Ventura S. Designing out disulfide bonds of leech carboxypeptidase inhibitor: implications for its folding, stability and function. J Mol Biol 392: 529-546, 2009.
7. Arolas JL, D'Silva L, Popowicz GM, Aviles FX, Holak TA, and Ventura S. NMR structural characterization and computational predictions of the major intermediate in oxidative folding of leech carboxypeptidase inhibitor. Structure 13: 1193-1202, 2005.
8. Arolas JL, Lorenzo J, Rovira A, Castella J, Aviles FX, and Sommerhoff CP. A carboxypeptidase inhibitor from the tick Rhipicephalus bursa: isolation, cDNA cloning, recombinant expression, and characterization. J Biol Chem 280: 3441-3448, 2005.
9. Arolas JL, Lorenzo J, Rovira A, Vendrell J, Aviles FX, and Ventura S. Secondary binding site of the potato carboxy-peptidase inhibitor. Contribution to its structure, folding, and biological properties. Biochemistry 43: 7973-7982, 2004.
10. Arolas JL, Pantoja-Uceda D, Ventura S, Blanco FJ, and Aviles FX. The NMR structures of the major intermediates of the two-domain tick carboxypeptidase inhibitor reveal symmetry in its folding and unfolding pathways. J Biol Chem 283: 27110-27120, 2008.
11. Arolas JL, Popowicz GM, Bronsoms S, Aviles FX, Huber R, Holak TA, and Ventura S. Study of a major intermediate in the oxidative folding of leech carboxypeptidase inhibitor: contribution of the fourth disulfide bond. J Mol Biol 352: 961-975, 2005. (Pubitemid 41267081)
12. Arolas JL, Popowicz GM, Lorenzo J, Sommerhoff CP, Huber R, Aviles FX, and Holak TA. The three-dimensional structures of tick carboxypeptidase inhibitor in complex with A=B carboxypeptidases reveal a novel double-headed binding mode. J Mol Biol 350: 489-498, 2005.
13. Arolas JL, Sanglas L, Lorenzo J, Bronsoms S, and Aviles FX. Insights into the two-domain architecture of the metallo-carboxypeptidase inhibitor from the Ascaris parasite inferred from the mechanism of its oxidative folding. Biochemistry 48: 8225-8232, 2009.
14. Auerswald EA, Morenweiser R, Sommerhoff CP, Piechottka GP, Eckerskorn C, Gurtler LG, and Fritz H. Recombinant leech-derived tryptase inhibitor: construction, production, protein chemical characterization and inhibition of HIV-1 replication., Biol Chem Hoppe Seyler, 375, 695-703, 1994.
15. Batey S, Scott KA, and Clarke J. Complex folding kinetics of a multidomain protein. Biophys J 90: 2120-2130, 2006.
16. Berndt KD, Guntert P, Orbons LP, and Wuthrich K. Determination of a high-quality nuclear magnetic resonance solution structure of the bovine pancreatic trypsin inhibitor and comparison with three crystal structures. J Mol Biol 227: 757-775, 1992.
17. Bode W and Huber R. Structural basis of the endoproteinase-protein inhibitor interaction. Biochim Biophys Acta 1477: 241-252, 2000.
18. Bronsoms S, Villanueva J, Canals F, Querol E, and Aviles FX. Analysis of the effect of potato carboxypeptidase inhibitor pro-sequence on the folding of the mature protein. Eur J Biochem 270: 3641-3650, 2003.
19. Cemazar M, Daly NL, Haggblad S, Lo KP, Yulyaningsih E, and Craik DJ. Knots in rings. The circular knotted protein Momordica cochinchinensis trypsin inhibitor-II folds via a stable two-disulfide intermediate. J Biol Chem 281: 8224-8232, 2006.
20. Cemazar M, Gruber CW, and Craik DJ. Oxidative folding of cyclic cystine knot proteins. Antioxid Redox Signal 10: 103-111, 2008.
21. Cemazar M, Joshi A, Daly NL, Mark AE, and Craik DJ. The structure of a two-disulfide intermediate assists in elucidating the oxidative folding pathway of a cyclic cystine knot protein. Structure 16: 842-851, 2008.
22. Craik DJ, Cemazar M, Wang CK, and Daly NL. The cyclo-tide family of circular miniproteins: nature's combinatorial peptide template. Biopolymers 84: 250-266, 2006.
23. Creighton TE. Renaturation of the reduced bovine pancreatic trypsin inhibitor. J Mol Biol 87: 563-577, 1974.
24. Creighton TE. Electrophoretic analysis of the unfolding of proteins by urea. J Mol Biol 129: 235-264, 1979.
25. Creighton TE. Toward a better understanding of protein folding pathways. Proc Natl Acad Sci USA 85: 5082-5086, 1988.
26. Creighton TE. Protein folding coupled to disulphide bond formation. Biol Chem 378: 731-744, 1997.
27. Creighton TE, Bagley CJ, Cooper L, Darby NJ, Freedman RB, Kemmink J, and Sheikh A. On the biosynthesis of bovine pancreatic trypsin inhibitor (BPTI). Structure, processing, folding and disulphide bond formation of the precursor in vitro and in microsomes. J Mol Biol 232: 1176-1196, 1993.
28. Creighton TE, Darby NJ, and Kemmink J. The roles of partly folded intermediates in protein folding. FASEB J 10: 110-118, 1996.
29. Creighton TE and Goldenberg DP. Kinetic role of a meta-stable native-like two-disulphide species in the folding transition of bovine pancreatic trypsin inhibitor. J Mol Biol 179: 497-526, 1984.
30. Chang JY. The functional domain of hirudin, a thrombin-specific inhibitor. FEBS Lett 164: 307-313, 1983.
31. Chang JY. The disulfide folding pathway of tick anticoagulant peptide (TAP), a Kunitz-type inhibitor structurally homologous to BPTI. Biochemistry 35: 11702-11709, 1996.
32. Chang JY. Evidence for the underlying cause of diversity of the disulfide folding pathway. Biochemistry 43: 4522-4529, 2004.
33. Chang JY. Diversity of folding pathways and folding models of disulfide proteins. Antioxid Redox Signal 10: 171-177, 2008.
34. Chang JY, Canals F, Schindler P, Querol E, and Aviles FX. The disulfide folding pathway of potato carboxypeptidase inhibitor. J Biol Chem 269: 22087-22094, 1994.
35. Chang JY and Li L. Divergent folding pathways of two homologous proteins, BPTI and tick anticoagulant peptide: compartmentalization of folding intermediates and identification of kinetic traps. Arch Biochem Biophys 437: 85-95, 2005.
36. Chang JY, Schindler P, and Chatrenet B. The disulfide structures of scrambled hirudins. J Biol Chem 270: 11992-11997, 1995.
37. Chatrenet B and Chang JY. The folding of hirudin adopts a mechanism of trial and error. J Biol Chem 267: 3038-3043, 1992.
38. Chatrenet B and Chang JY. The disulfide folding pathway of hirudin elucidated by stop=go folding experiments. J Biol Chem 268: 20988-20996, 1993.
39. Dadlez M. Hydrophobic interactions accelerate early stages of the folding of BPTI. Biochemistry 36: 2788-2797, 1997.
40. Darby NJ and Creighton TE. Dissecting the disulphide-coupled folding pathway of bovine pancreatic trypsin inhibitor. Forming the first disulphide bonds in analogues of the reduced protein. J Mol Biol 232: 873-896, 1993.
41. Di Marco S and Priestle JP. Structure of the complex of leech-derived tryptase inhibitor (LDTI) with trypsin and modeling of the LDTI-tryptase system. Structure 5: 1465-1474, 1997.
42. Felizmenio-Quimio ME, Daly NL, and Craik DJ. Circular proteins in plants: solution structure of a novel macrocyclic trypsin inhibitor from Momordica cochinchinensis. J Biol Chem 276: 22875-22882, 2001.
43. Folkers PJ, Clore GM, Driscoll PC, Dodt J, Kohler S, and Gronenborn AM. Solution structure of recombinant hirudin and the Lys-47-Glu mutant: a nuclear magnetic resonance and hybrid distance geometry-dynamical simulated annealing study. Biochemistry 28: 2601-2617, 1989.
44. Goldenberg DP and Zhang JX. Small effects of amino acid replacements on the reduced and unfolded state of pancreatic trypsin inhibitor. Proteins 15: 322-329, 1993.
45. Gonzalez C, Neira JL, Ventura S, Bronsoms S, Rico M, and Aviles FX. Structure and dynamics of the potato carboxy-peptidase inhibitor by 1H and 15N NMR. Proteins 50: 410-422, 2003.
46. Gottfried DS and Haas E. Nonlocal interactions stabilize compact folding intermediates in reduced unfolded bovine pancreatic trypsin inhibitor. Biochemistry 31: 12353-12362, 1992.
47. Grutter MG, Fendrich G, Huber R, and Bode W. The 2.5 A X-ray crystal structure of the acid-stable proteinase inhibitor from human mucous secretions analysed in its complex with bovine alpha-chymotrypsin. EMBO J 7: 345-351, 1988.
48. Grutter MG, Priestle JP, Rahuel J, Grossenbacher H, Bode W, Hofsteenge J, and Stone SR. Crystal structure of the throm-bin-hirudin complex: a novel mode of serine protease inhibition. EMBO J 9: 2361-2365, 1990.
49. Heitz A, Hernandez JF, Gagnon J, Hong TT, Pham TT, Nguyen TM, Le-Nguyen D, and Chiche L. Solution structure of the squash trypsin inhibitor MCoTI-II. A new family for cyclic knottins. Biochemistry 40: 7973-7983, 2001.
50. Housset D, Kim KS, Fuchs J, Woodward C, and Wlodawer A. Crystal structure of a Y35G mutant of bovine pancreatic trypsin inhibitor. J Mol Biol 220: 757-770, 1991.
51. Huber R, Kukla D, Bode W, Schwager P, Bartels K, Dei-senhofer J, and Steigemann W. Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. II. Crystallographic refinement at 1.9 A resolution. J Mol Biol 89: 73-101, 1974.
52. Kibria FM and Lees WJ. Balancing conformational and oxi-dative kinetic traps during the folding of bovine pancreatic trypsin inhibitor (BPTI) with glutathione and glutathione disulfide. J Am Chem Soc 130: 796-797, 2008.
53. Lim-Wilby MS, Hallenga K, de Maeyer M, Lasters I, Vlasuk GP, and Brunck TK. NMR structure determination of tick anticoagulant peptide (TAP). Protein Sci 4: 178-186, 1995.
54. Lin CC and Chang JY. Pathway of oxidative folding of secretory leucocyte protease inhibitor: an 8-disulfide protein exhibits a unique mechanism of folding. Biochemistry 45: 6231-6240, 2006.
55. Mamathambika BS and Bardwell JC. Disulfide-linked protein folding pathways. Annu Rev Cell Dev Biol 24: 211-235, 2008.
56. Muhlhahn P, Czisch M, Morenweiser R, Habermann B, Engh RA, Sommerhoff CP, Auerswald EA, and Holak TA. Structure of leech derived tryptase inhibitor (LDTI-C) in solution. FEBS Lett 355: 290-296, 1994.
57. Narayan M, Welker E, Wedemeyer WJ, and Scheraga HA. Oxidative folding of proteins. Acc Chem Res 33: 805-812, 2000.
58. Otlewski J, Jelen F, Zakrzewska M, and Oleksy A. The many faces of protease-protein inhibitor interaction. EMBO J 24: 1303-1310, 2005.
59. Pantoja-Uceda D, Arolas JL, Aviles FX, Santoro J, Ventura S, and Sommerhoff CP. Deciphering the structural basis that guides the oxidative folding of leech-derived tryptase inhibitor. J Biol Chem 284: 35612-35620, 2009.
60. Pantoja-Uceda D, Arolas JL, Garcia P, Lopez-Hernandez E, Padro D, Aviles FX, and Blanco FJ. The NMR structure and dynamics of the two-domain tick carboxypeptidase inhibitor reveal flexibility in its free form and stiffness upon binding to human carboxypeptidase B. Biochemistry 47: 7066-7078, 2008.
61. Plaxco KW, Simons KT, and Baker D. Contact order, transition state placement and the refolding rates of single domain proteins. J Mol Biol 277: 985-994, 1998.
62. Rawlings ND, Morton FR, Kok CY, Kong J, and Barrett AJ. MEROPS: the peptidase database. Nucleic Acids Res 36: D320-D325, 2008.
63. Rawlings ND, Tolle DP, and Barrett AJ. Evolutionary families of peptidase inhibitors. Biochem J 378: 705-716, 2004.
64. Rees DC and Lipscomb WN. Refined crystal structure of the potato inhibitor complex of carboxypeptidase A at 2.5 A resolution. J Mol Biol 160: 475-498, 1982.
65. Reverter D, Fernandez-Catalan C, Baumgartner R, Pfander R, Huber R, Bode W, Vendrell J, Holak TA, and Aviles FX. Structure of a novel leech carboxypeptidase inhibitor determined free in solution and in complex with human car-boxypeptidase A2. Nat Struct Biol 7: 322-328, 2000.
66. Reverter D, Vendrell J, Canals F, Horstmann J, Aviles FX, Fritz H, and Sommerhoff CP. A carboxypeptidase inhibitor from the medical leech Hirudo medicinalis. Isolation, sequence analysis, cDNA cloning, recombinant expression, and characterization. J Biol Chem 273: 32927-32933, 1998.
67. Ryan CA, Hass GM, and Kuhn RW. Purification and properties of a carboxypeptidase inhibitor from potatoes. J Biol Chem 249: 5495-5499, 1974.
68. Rydel TJ, Ravichandran KG, Tulinsky A, Bode W, Huber R, Roitsch C, and Fenton JW, 2nd. The structure of a complex of recombinant hirudin and human alpha-thrombin. Science 249: 277-280, 1990.
69. Salamanca S, Li L, Vendrell J, Aviles FX, and Chang JY. Major kinetic traps for the oxidative folding of leech car-boxypeptidase inhibitor. Biochemistry 42: 6754-6761, 2003.
70. Sanglas L, Aviles FX, Huber R, Gomis-Ruth FX, and Arolas JL. Mammalian metallopeptidase inhibition at the defense barrier of Ascaris parasite. Proc Natl Acad Sci USA 106: 1743-1747, 2009.
71. Sommerhoff CP and Schaschke N. Mast cell tryptase beta as a target in allergic inflammation: an evolving story. Curr Pharm Des 13: 313-332, 2007.
72. Sommerhoff CP, Sollner C, Mentele R, Piechottka GP, Auerswald EA, and Fritz H. A Kazal-type inhibitor of human mast cell tryptase: isolation from the medical leech Hirudo medicinalis, characterization, and sequence analysis. Biol Chem Hoppe Seyler 375: 685-694, 1994.
73. Stubbs MT, Morenweiser R, Sturzebecher J, Bauer M, Bode W, Huber R, Piechottka GP, Matschiner G, Sommerhoff CP, Fritz H, and Auerswald EA. The three-dimensional structure of recombinant leech-derived tryptase inhibitor in complex with trypsin. Implications for the structure of human mast cell tryptase and its inhibition. J Biol Chem 272: 19931-19937, 1997.
74. Thompson RC and Ohlsson K. Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc Natl Acad Sci USA 83: 6692-6696, 1986.
75. van Mierlo CP, Darby NJ, Keeler J, Neuhaus D, and Creighton TE. Partially folded conformation of the (30-51) intermediate in the disulphide folding pathway of bovine pancreatic trypsin inhibitor. 1H and 15N resonance assignments and determination of backbone dynamics from 15N relaxation measurements. J Mol Biol 229: 1125-1146, 1993.
76. Venhudova G, Canals F, Querol E, and Aviles FX. Mutations in the N- and C-terminal tails of potato carboxypeptidase inhibitor influence its oxidative refolding process at the reshuffling stage. J Biol Chem 276: 11683-11690, 2001.
77. Waxman L, Smith DE, Arcuri KE, and Vlasuk GP. Tick anticoagulant peptide (TAP) is a novel inhibitor of blood coagulation factor Xa. Science 248: 593-596, 1990.
78. Weissman JS and Kim PS. Reexamination of the folding of BPTI: predominance of native intermediates. Science 253: 1386-1393, 1991.
79. Weissman JS and Kim PS. Kinetic role of nonnative species in the folding of bovine pancreatic trypsin inhibitor. Proc Natl Acad Sci USA 89: 9900-9904, 1992.
80. Weissman JS and Kim PS. The pro region of BPTI facilitates folding. Cell 71: 841-851, 1992.
81. Welker E, Narayan M, Wedemeyer WJ, and Scheraga HA. Structural determinants of oxidative folding in proteins. Proc Natl Acad Sci USA 98: 2312-2316, 2001.